WHO ICTRP trial
To assess the efficacy of Radiofrequency Ablation (RFA) and Percutaneous acetic…
CTRI/2008/091/000061 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2008/091/000061 |
|---|---|
| Public title | To assess the efficacy of Radiofrequency Ablation (RFA) and Percutaneous acetic acid (PAI)for the management of small hepatocellular carcinoma (HCC) in patients of cirrhosis of liver and whether PAI is equally effective as RFA. |
| Scientific title | Randomized control trial (RCT) of Radiofrequency Ablation (RFA) and Percutaneous acetic acid (PAI) for the Treatment of Hepatocellular Carcinoma in Patients of Cirrhosis |
| Primary sponsor | Subrat Acharya |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Interventions | Intervention1: Ablation by Acetic acid: Not Applicable Control Intervention1: Ablation by radio frequency: Not Applicable |
| Registration date | Jul 18, 2008 |
| Target size | 74 |
| Secondary IDs | Protocol ID ICMR- D.O No.5/8/7/26/99-ECD-1 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: